Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in patients with carotid plaque with moderate stenosis
ChiCTR2100049986Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in carotid atheroma (CAS) and atherosclerotic carotid plaque comparing Experimental arm (idebenone) with Control arm (placebo/no idebenone) (2 arms). Primary endpoint: Plaque composition and stability. Started Jan 2021; status: recruiting.
02
Drugs
idebenone
03
Conditions
carotid atheroma (CAS)atherosclerotic carotid plaque
Beyond the preview
Go deeper on ChiCTR2100049986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049986.